PharmaShots | Incisive News in 3 Shots

Subscribe Now

Imara

Imara to Discontinue P-IIb (Ardent & Forte) Trial of Tovinontrine (IMR-687) for the Treatment of Sickle Cell Disease and Beta-Thalassemia

Imara to Discontinue P-IIb (Ardent & Forte) Trial of Tovinontrine (IMR-687) for the Treatment of Sickle Cell Disease and Beta-Thal...

April 5, 2022

Imara Reports the US FDA’s IND Clearance of Tovinontrine (IMR-687) for the Treatment of Heart Failure with Preserved Ejection Fraction

Imara Reports the US FDA’s IND Clearance of Tovinontrine (IMR-687) for the Treatment of Heart Failure with Preserved Ejection Frac...

January 27, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us